The company has strong prospects but an uncertain future.
News & Analysis: Catalyst Pharmaceuticals
These small-cap healthcare stocks are definitely worth checking out this month.
Here's why Catalyst's shareholder might want to simply shrug off yesterday's downturn.
Catalyst's latest bout of volatility could be a great buying opportunity for risk-tolerant investors.
These three biotech stocks could be great buys this month.
Shares drop after management announces a surprise capital raise. Here's what investors need to know.
CPRX earnings call for the period ending June 30, 2019.
Catalyst's shares took a sizable hit this morning.
The small-cap healthcare stocks Catalyst Pharmaceuticals and MedMen Enterprises have enormous upside potential.
Adverum Biotechnologies and Catalyst Pharmaceuticals could both post sizable gains next month.